JP2019514990A5 - - Google Patents

Download PDF

Info

Publication number
JP2019514990A5
JP2019514990A5 JP2018558730A JP2018558730A JP2019514990A5 JP 2019514990 A5 JP2019514990 A5 JP 2019514990A5 JP 2018558730 A JP2018558730 A JP 2018558730A JP 2018558730 A JP2018558730 A JP 2018558730A JP 2019514990 A5 JP2019514990 A5 JP 2019514990A5
Authority
JP
Japan
Prior art keywords
cannabidiol
nicotine
pharmaceutically effective
effective administration
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018558730A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019514990A (ja
JP6816167B2 (ja
Filing date
Publication date
Priority claimed from US15/426,617 external-priority patent/US10653639B2/en
Application filed filed Critical
Publication of JP2019514990A publication Critical patent/JP2019514990A/ja
Publication of JP2019514990A5 publication Critical patent/JP2019514990A5/ja
Application granted granted Critical
Publication of JP6816167B2 publication Critical patent/JP6816167B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018558730A 2016-05-16 2017-05-02 無煙タバコ中毒処置用のカンナビジオールおよびニコチンを含有する医薬製剤 Expired - Fee Related JP6816167B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662336990P 2016-05-16 2016-05-16
US62/336,990 2016-05-16
US15/426,617 2017-02-07
US15/426,617 US10653639B2 (en) 2016-05-16 2017-02-07 Pharmaceutical formulations containing cannabidiol and nicotine for treating smokeless tobacco addiction
PCT/US2017/030558 WO2017200740A1 (en) 2016-05-16 2017-05-02 Pharmaceutical formulations containing cannabidiol and nicotine for treating smokeless tobacco addiction

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020213562A Division JP7216697B2 (ja) 2016-05-16 2020-12-23 無煙タバコ中毒処置用のカンナビジオールおよびニコチンを含有する医薬製剤

Publications (3)

Publication Number Publication Date
JP2019514990A JP2019514990A (ja) 2019-06-06
JP2019514990A5 true JP2019514990A5 (enExample) 2020-06-18
JP6816167B2 JP6816167B2 (ja) 2021-01-20

Family

ID=60297254

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018558730A Expired - Fee Related JP6816167B2 (ja) 2016-05-16 2017-05-02 無煙タバコ中毒処置用のカンナビジオールおよびニコチンを含有する医薬製剤
JP2020213562A Active JP7216697B2 (ja) 2016-05-16 2020-12-23 無煙タバコ中毒処置用のカンナビジオールおよびニコチンを含有する医薬製剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020213562A Active JP7216697B2 (ja) 2016-05-16 2020-12-23 無煙タバコ中毒処置用のカンナビジオールおよびニコチンを含有する医薬製剤

Country Status (8)

Country Link
US (2) US10653639B2 (enExample)
EP (2) EP3458057B1 (enExample)
JP (2) JP6816167B2 (enExample)
CN (1) CN109152773A (enExample)
AU (2) AU2017267927B2 (enExample)
CA (1) CA3021835C (enExample)
ES (1) ES2898342T3 (enExample)
WO (1) WO2017200740A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL2018504B1 (en) * 2017-03-13 2018-09-21 Pharma Unlimited B V Tobacco- and smoke-less products consumable by humans as epicurean or medical products and method of treating smoking addiction
US11166910B2 (en) * 2019-01-25 2021-11-09 Nordiccan A/S Cannabinoid chewing gum with sugar alcohols
US11253473B2 (en) * 2019-03-01 2022-02-22 Nordiccan A/S Method of producing tableted cannabinoid chewing gum
CN111789881A (zh) * 2019-04-04 2020-10-20 昆明医科大学 一种工业大麻提取物的用途
EP3946262B1 (en) * 2019-08-30 2024-07-31 Evie Sa Loaded granules, their process of production and their uses
CN113100490A (zh) * 2021-05-21 2021-07-13 张家港外星人新材料科技有限公司 生物碱与酚反应合成物、雾化液、雾化弹及电子雾化器

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3901248A (en) 1970-07-22 1975-08-26 Leo Ab Chewable smoking substitute composition
CA2075517C (en) 1992-04-01 1997-03-11 John Wick Transdermal patch incorporating a polymer film incorporated with an active agent
US5948433A (en) 1997-08-21 1999-09-07 Bertek, Inc. Transdermal patch
US20020098264A1 (en) 1998-11-27 2002-07-25 Cherukuri Subraman R. Medicated chewing gum delivery system for nicotine
FR2788982B1 (fr) * 1999-02-02 2002-08-02 Synthelabo Compositions pharmaceutiques contenant de la nicotine et leur application dans le sevrage tabagique
US20030159702A1 (en) * 2002-01-21 2003-08-28 Lindell Katarina E.A. Formulation and use manufacture thereof
FI113340B (fi) 2002-02-20 2004-04-15 Tomi Jaervinen Uudet luonnon syklodekstriinin kompleksit
GB0712308D0 (en) 2007-06-25 2007-08-01 Kind Group Ltd An inhalable composition
GB2450753B (en) 2007-07-06 2012-07-18 Gw Pharma Ltd New Pharmaceutical formulation
WO2009080022A1 (en) * 2007-12-20 2009-07-02 Fertin Pharma A/S Compressed chewing gum tablet
US9023322B2 (en) 2008-03-26 2015-05-05 Stichting Sanammad Chewing gum compositions comprising cannabinoids
GB2464752B (en) * 2008-10-24 2010-09-08 Anna Louise Bullus Chewing gum composition
MX353752B (es) 2009-01-20 2018-01-26 Los Angeles Biomedical Res Inst Harbor Ucla Medical Ct Los ácidos sórbico y benzoico y sus derivados aumentan la actividad de un neurofármaco.
ES2607209T3 (es) 2009-02-06 2017-03-29 Egalet Ltd. Composiciones farmacéuticas resistentes al abuso
US20100247586A1 (en) 2009-03-27 2010-09-30 Andreas Hugerth Multi-Portion Intra-Oral Dosage Form With Organoleptic Properties
EP2233134A1 (en) 2009-03-27 2010-09-29 McNeil AB Multi-portion intra-oral dosage form with organoleptic properties
US20140166208A1 (en) * 2011-06-27 2014-06-19 Iq Tec Switzerland Gmbh Preforming pre-preg
US8623332B2 (en) 2011-07-06 2014-01-07 Fertin Pharma A/S Chewing gum having sustained release of nicotine
WO2013091631A1 (en) 2011-12-22 2013-06-27 Fertin Pharma A/S Method of releasing nicotine from chewing gum
US20140166028A1 (en) 2012-12-14 2014-06-19 Richard C. Fuisz Enhanced Delivery of Nicotine, THC, Tobacco, Cannabidiol or Base Alkaloid from an Electronic Cigarette or Other Vapor or Smoke Producing Device Through Use of an Absorption Conditioning Unit
US10639439B2 (en) 2013-01-30 2020-05-05 Midwest Pharmaceuticals, Llc Smokeless THC and administration method thereof
US10792318B2 (en) 2013-03-14 2020-10-06 Sc Laboratories, Inc. Bioactive concentrates and uses thereof
WO2015025312A1 (en) 2013-08-21 2015-02-26 Cannabics Pharmaceuticals Inc Compositions for combined immediate and sustained release of cannabinoids, methods of manufacture and use thereof
US9326967B2 (en) 2013-08-22 2016-05-03 Stephen C. Perry Vaporizable cannabinoid compositions
US10842786B2 (en) 2016-04-27 2020-11-24 Apirx Pharmaceutical Usa, Llc Chewing gum composition comprising cannabinoids and nicotine

Similar Documents

Publication Publication Date Title
Malhotra et al. Nicotine and periodontal tissues
US11583519B2 (en) Nasal compositions and method of use thereof
HRP20210487T1 (hr) Farmaceutski sastavi koji sadrže lokalni anestetik kao što je bupivakain za lokalnu primjenu u usta ili grlo
US20170007594A1 (en) Therapeutic composition and configuration
EP4631571A3 (en) Combination of dextromethorphan and bupropion for treating depression
JP2010535805A5 (enExample)
NO20043723L (no) Farmasoytisk doseringform for avgivese gjennom slimhinner
JP2011516521A5 (enExample)
AR045289A1 (es) Forma de dosificacion oral de liberacion controlada que comprende 4-(2-di-n-propilaminoetil) - 2(3h)-indolona (ropi-nirol) y uso de dicha forma de dosificacion para la elaboracion de un medicamento
JP2016525548A5 (enExample)
JP2025081331A5 (enExample)
CL2024003601A1 (es) Nuevas combinaciones terapéuticas para el tratamiento de enfermedades pulmonares intersticiales fibrosantes progresivas.
WO2010003472A3 (de) Lutschzusammensetzung zur behandlung von entzündlichen erkrankungen des mund- und rachenraums
JP2013523628A5 (enExample)
JP2016505050A5 (enExample)
CA2654477A1 (en) Smoking withdrawal combination wafer
JP2016537364A5 (enExample)
Talwar et al. Pharmacotherapy of tobacco dependence
JP2009534367A5 (enExample)
WO2021112812A2 (en) Orally dissolving mucoadhesive films utilizing menthol and l-arginine to enhance the bioavailability of cannabinoids
JP2006508994A5 (enExample)
CN107519152A (zh) 一种口腔溃疡膜及其制备方法
WO2018169387A1 (en) Tobacco- and smoke-less products consumable by humans as epicurean or medical products and method of treating smoking addiction
JP2017511307A5 (enExample)
US20020168403A1 (en) Compositions and therapy for substance addiction